February 2020 Issue Table Of Contents

From The Editor

• What Biopharmas Could Learn About Reinvention — From Outsiders

Feature Articles

• Allogene Therapeutics — The Juggernaut Built On Kite’s Flight
• Why John Sculley Views Healthcare As His “Noble Cause”

Capitol Perspectives

• The Bipartisan Dismemberment Of The ACA

From Principles and Policy to Execution

• Demographically Appropriate Policies Deliver Sustainable Care And Healthy Populations

Companies To Watch

• Imago BioSciences

Patient Perspectives

• Patients Pay It Forward With My Mentor Connections

Industry Research

• Sole Sourcing Arrangements For Central Labs

Inside The Industry

• Can Integrated Service Providers Help Simplify Complex Clinical Trial Logistics?
• 3 Ways Pharma Manufacturers Can Foster Patient Trust
• How Biopharma Can Compete For Top Tech Skills
• An Analysis Of The FDA’s Drug Shortages Root Cause Report
• Medtech Patents in China: New Guidance From China
• A Global Biotech Player From Down Under
• Artificial Intelligence: The Accelerating Force For Life Sciences Startups
• Bridging The Gap Between Big Pharma And The American Public
• The Ins And Outs Of Board Service: What We Now Know
• Clinical Trial SOS

Leadership Lessons

• Why Vulnerability Is A Leadership Superpower

Ask The Board

• What Was The Most Challenging Experience You’ve Encountered As A Leader?
• What Was The Best Piece Of Leadership Advice You’ve Ever Received?
• What Are Some Of The Best Practices You’ve Observed Being Implemented That Positively Impacted A Company’s Corporate Culture?